A MULTICENTER, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EXPLORE THE LONG-TERM SAFETY OF TEV-48125 FOR THE PREVENTION OF CLUSTER HEADACHE

Registry ID

TV48125-CNS-30058

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D INC

Start date

2017-11-20

Last update

2017-03-23

Conditions

• CHRONIC CLUSTER HEADACHE

Related clinical trials

• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO CONTROLLED, PARALLEL GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF 2 DOSE REGIMENS (INTRAVENOUS/SUBCUTANEOUS AND SUBCUTANEOUS) OF TEV-48125 VERSUS PLACEBO FOR THE PREVENTION OF CHRONIC CLUSTER HEADACHE

View on source registry